434 related articles for article (PubMed ID: 21609225)
1. Nutritional supplementation and age-related macular degeneration.
Olson JH; Erie JC; Bakri SJ
Semin Ophthalmol; 2011 May; 26(3):131-6. PubMed ID: 21609225
[TBL] [Abstract][Full Text] [Related]
2. [Macular pigment and age-related macular degeneration. Clinical implications].
Haddad WM; Souied E; Coscas G; Soubrane G
Bull Soc Belge Ophtalmol; 2006; (301):15-22. PubMed ID: 17552428
[TBL] [Abstract][Full Text] [Related]
3. [Nutrition and age-related macular degeneration].
Desmettre T; Lecerf JM; Souied EH
J Fr Ophtalmol; 2004 Nov; 27(9 Pt 2):3S38-56. PubMed ID: 15602406
[TBL] [Abstract][Full Text] [Related]
4. Nutritional supplements for age-related macular degeneration.
Krishnadev N; Meleth AD; Chew EY
Curr Opin Ophthalmol; 2010 May; 21(3):184-9. PubMed ID: 20216418
[TBL] [Abstract][Full Text] [Related]
5. Age related macular degeneration--should your patients be taking additional supplements?
Jones AA
Aust Fam Physician; 2007 Dec; 36(12):1026-8. PubMed ID: 18075628
[TBL] [Abstract][Full Text] [Related]
6. [Vitamins for prevention of age related macular degeneration: efficacy and risk].
Cohen SY
Bull Soc Belge Ophtalmol; 2006; (301):33-6. PubMed ID: 17552430
[TBL] [Abstract][Full Text] [Related]
7. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
Age-Related Eye Disease Study 2 Research Group
JAMA; 2013 May; 309(19):2005-15. PubMed ID: 23644932
[TBL] [Abstract][Full Text] [Related]
8. Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
; Bonds DE; Harrington M; Worrall BB; Bertoni AG; Eaton CB; Hsia J; Robinson J; Clemons TE; Fine LJ; Chew EY
JAMA Intern Med; 2014 May; 174(5):763-71. PubMed ID: 24638908
[TBL] [Abstract][Full Text] [Related]
9. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study.
Trieschmann M; Beatty S; Nolan JM; Hense HW; Heimes B; Austermann U; Fobker M; Pauleikhoff D
Exp Eye Res; 2007 Apr; 84(4):718-28. PubMed ID: 17306793
[TBL] [Abstract][Full Text] [Related]
10. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.
; Chew EY; Clemons TE; Sangiovanni JP; Danis RP; Ferris FL; Elman MJ; Antoszyk AN; Ruby AJ; Orth D; Bressler SB; Fish GE; Hubbard GB; Klein ML; Chandra SR; Blodi BA; Domalpally A; Friberg T; Wong WT; Rosenfeld PJ; Agrón E; Toth CA; Bernstein PS; Sperduto RD
JAMA Ophthalmol; 2014 Feb; 132(2):142-9. PubMed ID: 24310343
[TBL] [Abstract][Full Text] [Related]
11. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).
; Chew EY; Clemons T; SanGiovanni JP; Danis R; Domalpally A; McBee W; Sperduto R; Ferris FL
Ophthalmology; 2012 Nov; 119(11):2282-9. PubMed ID: 22840421
[TBL] [Abstract][Full Text] [Related]
12. Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28.
Chew EY; Clemons TE; Agrón E; Domalpally A; Keenan TDL; Vitale S; Weber C; Smith DC; Christen W;
JAMA Ophthalmol; 2022 Jul; 140(7):692-698. PubMed ID: 35653117
[TBL] [Abstract][Full Text] [Related]
13. An ideal ocular nutritional supplement?
Bartlett H; Eperjesi F
Ophthalmic Physiol Opt; 2004 Jul; 24(4):339-49. PubMed ID: 15228513
[TBL] [Abstract][Full Text] [Related]
14. No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18.
van Asten F; Chiu CY; Agrón E; Clemons TE; Ratnapriya R; Swaroop A; Klein ML; Fan R; Chew EY;
Ophthalmology; 2019 Nov; 126(11):1541-1548. PubMed ID: 31358387
[TBL] [Abstract][Full Text] [Related]
15. Nutritional supplements in the prevention of age-related macular degeneration.
Blodi BA
Insight; 2004; 29(1):15-6; quiz 17-8. PubMed ID: 15077399
[TBL] [Abstract][Full Text] [Related]
16. [Micronutrients and their relevance for the eye--function of lutein, zeaxanthin and omega-3 fatty acids].
Schweigert FJ; Reimann J
Klin Monbl Augenheilkd; 2011 Jun; 228(6):537-43. PubMed ID: 20740395
[TBL] [Abstract][Full Text] [Related]
17. Nutritional supplementation in age-related macular degeneration.
Coleman H; Chew E
Curr Opin Ophthalmol; 2007 May; 18(3):220-3. PubMed ID: 17435429
[TBL] [Abstract][Full Text] [Related]
18. Nutritional supplements in age-related macular degeneration.
Schmidl D; Garhöfer G; Schmetterer L
Acta Ophthalmol; 2015 Mar; 93(2):105-21. PubMed ID: 25586104
[TBL] [Abstract][Full Text] [Related]
19. Age-related Eye Disease Study 2: perspectives, recommendations, and unanswered questions.
Aronow ME; Chew EY
Curr Opin Ophthalmol; 2014 May; 25(3):186-90. PubMed ID: 24614146
[TBL] [Abstract][Full Text] [Related]
20. Evidence-based nutritional advice for patients affected by age-related macular degeneration.
Andreatta W; El-Sherbiny S
Ophthalmologica; 2014; 231(4):185-90. PubMed ID: 24821294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
